The Paradromics Difference
Our BCI platform has demonstrated information transfer rates above 200 bits per second, 20x faster than any other BCI technology, and our core architecture is designed to scale electrode count and data rate across future generations. As BCI applications become more capable and complex, greater neural bandwidth will create the foundation for richer communication, control, AI integration, and entirely new applications.
A permanent neural interface should be built for the life of the person who depends on it. Connexus® BCI is engineered with durable, biocompatible materials and an architecture designed to support stable neural recording for a decade or more, reducing the potential need for repeat brain surgeries and giving patients greater confidence in the technology they rely on.
Connexus BCI is designed around established neurosurgical techniques, familiar clinical workflows, and medical-grade materials, helping reduce the specialized infrastructure required to bring BCI technology into clinical practice and supporting broader access as the platform expands. No proprietary robots. Just good surgeons.
The Next Frontier of Human Capability
Built to support the next generation of BCI applications
From restoring communication and control today to enabling new forms of interaction with technology tomorrow. By connecting high-performance modules with different regions of the brain, the platform can support increasingly advanced applications and, over time, multiple functions through a single neural interface.
Platform Capable Technology
In the future, our BCI platform will be able to access different
areas of the brain, extending from essential functions like
speech and motor skills to broader human capabilities.
In the future, our BCI platform will be able to access different areas of the brain, extending from essential functions like speech and motor skills to broader human capabilities.
-
Directly control the motor pathways involved in speech production, restoring the ability to communicate verbally for people who have lost the physical capacity to speak.
-
Precise control over the physical and digital world, including robotic limb control, cursor movement, and other motor activities.
-
Decode how the brain understands and generates language, enabling natural speech synthesis and perception even when the pathways between thought and sound are disrupted.
-
Access the neural circuits that govern mood, focus, and decision-making, opening the door to therapies for cognitive and psychiatric conditions.
-
Restore the sense of touch and body position by relaying sensory feedback directly to the brain, enabling more natural and intuitive control of prosthetic and robotic devices.
-
Translate intended movement into precise robotic control, enabling reaching and grasping with the speed and dexterity of a natural limb.
-
Send visual information directly to the brain to restore sight and potentially enable new forms of vision, from enhanced detail to expanded light and thermal perception.
Our BCI platform will lead to life-changing therapies
and unprecedented capabilities for human-technology integration.
Our Products
Connexus® BCI
Designed for real-time speech, plus digital device control.
Current FDA-Authorized Human Clinical Study
Connexus BCI is an investigational device limited by United States law to investigational.
Tempo™ BCI
Designed for ambulatory users and mobile BCI applications.
Pre-Clinical Trial Phase
Tempo BCI is in a pre-clinical-trial phase.